Silo Pharma Inc.

NASDAQ: SILO · Real-Time Price · USD
0.70
-0.01 (-1.41%)
At close: Aug 18, 2025, 10:47 AM

Silo Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 72.1K 122.16K 151.57K 155.67K 153.93K 88.06K
Cost of Revenue
5.84K -167.51K 5.84K 166.73K 166.73K 340.07K 166.73K 5.84K 5.84K 5.84K 5.84K 5.84K 5.84K 42.88K 73.36K 217.16K 245.16K 207.99K
Gross Profit
66.26K 239.61K 66.26K -94.62K -94.62K -267.97K -94.62K 66.26K 66.26K 66.26K 66.26K 66.26K 66.26K 79.29K 78.2K -61.49K -91.22K -119.93K
Operating Income
-5.17M -4.92M -4.71M -4.06M -3.82M -3.93M -3.86M -4.35M -4.52M -3.9M -3.65M -2.93M -2.45M -2.46M -2.88M -2.72M -2.9M -3.38M
Interest Income
229.77K 306.82K 333.17K 358.54K 389.78K 422.32K 398.53K 361.01K 245.82K 136.61K 72.64K 2.98K 2K 1.63K 1.21K 2.75K 5.57K 8.51K
Pretax Income
-4.9M -4.62M -4.39M -3.71M -3.45M -3.53M -3.63M -4.24M -4.57M -4.21M -3.91M -3.3M 4.17M 4.37M 4.04M 4.31M -2.82M -3.73M
Net Income
-4.9M -4.62M -4.39M -3.78M -3.51M -3.6M -3.7M -4.24M -4.6M -4.41M -4.11M -3.53M 3.87M 4.23M 3.9M 4.2M -2.82M -3.73M
Selling & General & Admin
1.38M 1.96M 2.02M 2.11M 2.66M 3.04M 3.08M 3.27M 3.25M 2.65M 2.43M 1.94M 1.79M 1.85M 2.38M 2.38M 2.46M 2.98M
Research & Development
2.9M 2.58M 2.3M 1.57M 1.22M 960.42K 845.09K 1.14M 1.34M 1.32M 1.29M 1.13M 822.42K 829.24K 726.95K 286.11K 232.96K 121.77K
Other Expenses
760.14K 266.7K 448.26K 448.26K n/a n/a n/a n/a n/a -283 -283 -283 -283 n/a n/a n/a n/a 3K
Operating Expenses
5.05M 4.8M 4.77M 4.12M 3.89M 4M 3.92M 4.42M 4.59M 3.97M 3.71M 3.06M 2.61M 2.68M 3.11M 2.66M 2.69M 3.1M
Interest Expense
-2.36K 1.15K 5.08K 5.08K 5.08K 5.08K 4.87K 76.25K 75.17K 73.31K 71.66K 164.00 647.00 1.69K 3.04K 2.92K 2.83K 188.06K
Selling & Marketing Expenses
-199.54K -199.54K -199.54K -199.54K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
5.23M 4.99M 4.77M 4.13M 3.89M 4M 3.93M 4.42M 4.6M 3.98M 3.72M 3.07M 2.62M 2.73M 3.18M 2.88M 2.94M 3.31M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a 1.16K 34.27K 198.01K 199.18K 203.76K 189.78K 26.04K 33.73K 27.98K -78.58K -78.58K
Shares Outstanding (Basic)
6.28M 4.48M 4.48M 4.3M 3.05M 2.87M 2.91M 3.11M 3.15M 3.16M 2.14M 2M 1.99M 1.97M 1.9M 1.97M 1.94M 1.7M
Shares Outstanding (Diluted)
6.28M 4.48M 4.48M 4.3M 3.05M 2.87M 2.91M 3.11M 3.15M 3.16M 2.14M 2M 1.99M 1.97M 1.92M 1.99M 1.94M 1.7M
EPS (Basic)
-1.03 -1.15 -1.2 -1.2 -1.19 -1.2 -1.21 -1.6 -1.9 -1.99 -2.01 -1.8 1.87 2.04 1.80 1.77 -1.77 -3.49
EPS (Diluted)
-1.03 -1.15 -1.2 -1.2 -1.19 -1.2 -1.21 -1.6 -1.9 -1.99 -2.01 -1.8 1.87 2.04 1.80 1.77 -1.77 -3.49
EBITDA
-5.06M -4.74M -4.45M -3.71M -3.44M -3.52M -3.63M -4.42M -4.71M -4.19M -3.81M -3.03M -2.54M -2.56M -2.96M -2.6M -2.69M -3.37M
EBIT
-3.69M -4.62M -4.39M -3.71M -3.44M -3.52M -3.63M -4.49M -4.81M -4.46M -4.16M -3.3M -2.81M -2.64M -2.96M -2.7M -2.84M -3.54M
Depreciation & Amortization
9.28K -34K 6.18K 3.09K n/a 152.86K 8.33K -174.38K -139.31K -84.68K 72.64K 114.99K 49.91K -160.3K -223.86K 631.00 118.45K 170.39K